[Evaluation of Antiretroviral Therapy on Mother to Child Transmission HIV in HIV-1 Positive Pregnant Women: Case of St. Camillus Medical Center in Ouagadougou, Burkina Faso]

Overview

Journal Pan Afr Med J

Date 2015 Aug 25

PMID 26301003

Citations 6

Authors

Serge Theophile Soubeiga

Rebecca Compaore

Florencia Djigma

Nicaise Zagre

Elsa Assengone

Lassina Traore

Birama Diarra

Cyrille Bisseye

Djeneba Ouermi

Tani Sagna

Simplice Karou

Virginio Pietra

Jacques Simpore

Affiliations

Soon will be listed here.

Citing Articles

Optimization of the vertical transmission prevention program in Guinea: impact of the improvement plan on performance indicators at large-cohort sites.

Camara S, Millimouno T, Hounmenou C, Kolie D, Kadio K, Sow A AIDS Res Ther. 2024; 21(1):55.

PMID: 39182113 PMC: 11344318. DOI: 10.1186/s12981-024-00639-y.

Availability and readiness of the health facilities to provide HIV counseling and testing and prevention of mother-to-child transmission services in Burkina Faso: a trend analysis from 2012 to 2018.

Fassinou L, Hien H, Yombi J, Nagot N, Kirakoya-Samadoulougou F BMC Health Serv Res. 2023; 23(1):757.

PMID: 37452422 PMC: 10347843. DOI: 10.1186/s12913-023-09757-1.

Clinico-epidemiological profile of children living with HIV/AIDS managed at Heal Africa Hospital, Goma, Democratic Republic of the Congo.

Mapera E, Fina J, Mabiala J, Ngwala L, Nzaumvila D Afr Health Sci. 2023; 22(4):435-442.

PMID: 37092049 PMC: 10117496. DOI: 10.4314/ahs.v22i4.49.

Uptake of prevention of mother-to-child transmission cascade services in Burkina Faso between 2013 and 2020: are we on the right track?.

Fassinou L, Ouoba J, Ngwasiri C, Romba I, Zoungrana-Yameogo W, Bakiono F BMC Womens Health. 2023; 23(1):126.

PMID: 36959578 PMC: 10036241. DOI: 10.1186/s12905-023-02227-0.

Prevention of mother-to-child transmission (PMTCT) of HIV: a review of the achievements and challenges in Burkina-Faso.

Ghoma Linguissi L, Sagna T, Soubeiga S, Gwom L, Nkenfou C, Obiri-Yeboah D HIV AIDS (Auckl). 2019; 11:165-177.

PMID: 31440104 PMC: 6664853. DOI: 10.2147/HIV.S204661.

References

Kourtis A, Bulterys M, Nesheim S, Lee F . Understanding the timing of HIV transmission from mother to infant. JAMA. 2001; 285(6):709-12. DOI: 10.1001/jama.285.6.709. View

Hazen R, Harvey R, St Clair M, Ferris R, Freeman G, Tidwell J . Anti-human immunodeficiency virus type 1 activity of the nonnucleoside reverse transcriptase inhibitor GW678248 in combination with other antiretrovirals against clinical isolate viruses and in vitro selection for resistance. Antimicrob Agents Chemother. 2005; 49(11):4465-73. PMC: 1280120. DOI: 10.1128/AAC.49.11.4465-4473.2005. View

Ghoma Linguissi L, Bisseye C, Sagna T, Nagalo B, Ouermi D, Djigma F . Efficiency of HAART in the prevention of mother to children HIV-1 transmission at Saint Camille medical centre in Burkina Faso, West Africa. Asian Pac J Trop Med. 2012; 5(12):991-4. DOI: 10.1016/S1995-7645(12)60188-6. View

Kouanda S, Tougri H, Cisse M, Simpore J, Pietra V, Doulougou B . Impact of maternal HAART on the prevention of mother-to-child transmission of HIV: results of an 18-month follow-up study in Ouagadougou, Burkina Faso. AIDS Care. 2010; 22(7):843-50. DOI: 10.1080/09540120903499204. View

Goetghebuer T, Haelterman E, Chenadec J, Dollfus C, Gibb D, Judd A . Effect of early antiretroviral therapy on the risk of AIDS/death in HIV-infected infants. AIDS. 2009; 23(5):597-604. DOI: 10.1097/QAD.0b013e328326ca37. View

Chi B, Sinkala M, Mbewe F, Cantrell R, Kruse G, Chintu N . Single-dose tenofovir and emtricitabine for reduction of viral resistance to non-nucleoside reverse transcriptase inhibitor drugs in women given intrapartum nevirapine for perinatal HIV prevention: an open-label randomised trial. Lancet. 2007; 370(9600):1698-705. DOI: 10.1016/S0140-6736(07)61605-5. View

Arrive E, Newell M, Ekouevi D, Chaix M, Thiebaut R, Masquelier B . Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis. Int J Epidemiol. 2007; 36(5):1009-21. DOI: 10.1093/ije/dym104. View

Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega W, Ilboudo D . Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol. 2007; 79(7):873-9. DOI: 10.1002/jmv.20913. View

Nadembega W, Giannella S, Simpore J, Ceccherini-Silberstein F, Pietra V, Bertoli A . Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso. J Med Virol. 2006; 78(11):1385-91. DOI: 10.1002/jmv.20709. View

10.

Pignatelli S, Simpore J, Pietra V, Ouedraogo L, Conombo G, Saleri N . Factors predicting uptake of voluntary counselling and testing in a real-life setting in a mother-and-child center in Ouagadougou, Burkina Faso. Trop Med Int Health. 2006; 11(3):350-7. DOI: 10.1111/j.1365-3156.2006.01564.x. View

11.

Chaix M, Ekouevi D, Rouet F, Tonwe-Gold B, Viho I, Bequet L . Low risk of nevirapine resistance mutations in the prevention of mother-to-child transmission of HIV-1: Agence Nationale de Recherches sur le SIDA Ditrame Plus, Abidjan, Cote d'Ivoire. J Infect Dis. 2006; 193(4):482-7. DOI: 10.1086/499966. View

12.

Simpore J, Pietra V, Savadogo A, Pignatelli S, Nikiema J, Nadembega W . Reduction of mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso. J Med Virol. 2005; 78(2):148-52. DOI: 10.1002/jmv.20521. View

13.

Leroy V, Karon J, Alioum A, Ekpini E, Van de Perre P, Greenberg A . Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa. AIDS. 2003; 17(10):1493-501. DOI: 10.1097/00002030-200307040-00010. View

14.

Coutsoudis A, Dabis F, Fawzi W, Gaillard P, Haverkamp G, Harris D . Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis. 2004; 189(12):2154-66. DOI: 10.1086/420834. View

15.

Faye A, Chenadec J, Dollfus C, Thuret I, Douard D, Firtion G . Early versus deferred antiretroviral multidrug therapy in infants infected with HIV type 1. Clin Infect Dis. 2004; 39(11):1692-8. DOI: 10.1086/425739. View

16.

Shapiro R, Ndungu T, Lockman S, Smeaton L, Thior I, Wester C . Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis. 2005; 192(5):713-9. DOI: 10.1086/432489. View

17.

Ferris R, Hazen R, Roberts G, St Clair M, Chan J, Romines K . Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitor. Antimicrob Agents Chemother. 2005; 49(10):4046-51. PMC: 1251513. DOI: 10.1128/AAC.49.10.4046-4051.2005. View

18.

Leroy V, Sakarovitch C, Cortina-Borja M, McIntyre J, Coovadia H, Dabis F . Is there a difference in the efficacy of peripartum antiretroviral regimens in reducing mother-to-child transmission of HIV in Africa?. AIDS. 2005; 19(16):1865-75. DOI: 10.1097/01.aids.0000188423.02786.55. View

19.

Bacheler L, Jeffrey S, Hanna G, DAquila R, Wallace L, Logue K . Genotypic correlates of phenotypic resistance to efavirenz in virus isolates from patients failing nonnucleoside reverse transcriptase inhibitor therapy. J Virol. 2001; 75(11):4999-5008. PMC: 114903. DOI: 10.1128/JVI.75.11.4999-5008.2001. View